Wedbush Securities’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,625
Closed -$163K 1257
2025
Q4
$163K Buy
10,625
+25
+0.2% +$275 ﹤0.01% 1139
2025
Q3
$105K Sell
10,600
-581
-5% -$6.05K ﹤0.01% 1131
2025
Q2
$111K Sell
11,181
-271
-2% -$2.86K ﹤0.01% 1105
2025
Q1
$149K Sell
11,452
-288
-2% -$3.81K 0.01% 1036
2024
Q4
$150K Sell
11,740
-1,445
-11% -$17.5K 0.01% 1057
2024
Q3
$147K Sell
13,185
-1,345
-9% -$14.8K 0.01% 1025
2024
Q2
$163K Sell
14,530
-4,050
-22% -$47.1K 0.01% 1098
2024
Q1
$231K Buy
18,580
+3,080
+20% +$40.2K 0.01% 1013
2023
Q4
$217K Hold
15,500
0.01% 923
2023
Q3
$229K Hold
15,500
0.01% 855
2023
Q2
$200K Sell
15,500
-2,000
-11% -$22.8K 0.01% 933
2023
Q1
$172K Hold
17,500
0.01% 969
2022
Q4
$186K Sell
17,500
-2,000
-10% -$23.2K 0.01% 929
2022
Q3
$204K Sell
19,500
-1,000
-5% -$13K 0.01% 892
2022
Q2
$258K Hold
20,500
0.01% 809
2022
Q1
$222K Sell
20,500
-500
-2% -$6.07K 0.01% 942
2021
Q4
$295K Buy
21,000
+3,000
+17% +$49.4K 0.01% 878
2021
Q3
$346K Sell
18,000
-15,700
-47% -$208K 0.02% 787
2021
Q2
$332K Buy
33,700
+7,200
+27% +$65.5K 0.02% 816
2021
Q1
$260K Sell
26,500
-3,000
-10% -$24.7K 0.01% 875
2020
Q4
$131K Buy
29,500
+5,000
+20% +$22.6K 0.01% 817
2020
Q3
$106K Buy
24,500
+9,000
+58% +$64.2K 0.01% 823
2020
Q2
$137K Buy
15,500
+5,000
+48% +$25.3K 0.01% 831
2020
Q1
$37K Hold
10,500
﹤0.01% 841
2019
Q4
$60K Hold
10,500
0.01% 957
2019
Q3
$38K Hold
10,500
﹤0.01% 955
2019
Q2
$42K Buy
+10,500
New +$60.9K ﹤0.01% 955
2014
Q1
Sell
-4,350
Closed -$85K 636
2013
Q4
$85K Buy
4,350
+500
+13% +$7.32K 0.02% 537
2013
Q3
$46K Hold
3,850
0.01% 545
2013
Q2
$42K Buy
+3,850
New +$81.1K 0.01% 528

Other funds holding DVAX

Wedbush Securities's DVAX Position: Q1 2026 in Review

Wedbush Securities sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 10,625 shares — an estimated $163K sold.

Wedbush Securities first reported a position in DVAX in Q2 2013 and held it in 30 quarters. The position peaked at $346K in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Wedbush Securities reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Wedbush Securities sold 10,625 Dynavax Technologies shares in Q1 2026, an estimated $163K.
  • Wedbush Securities first reported a position in Dynavax Technologies in Q2 2013 and held it in 30 quarters.
  • Wedbush Securities's Dynavax Technologies position peaked at $346K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.